- Supported exchanges /
- F /
- 5KW.F
SKINBIO THERAP LS-01 (5KW F) stock market data APIs
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.
SKINBIO THERAP LS-01 Financial Data Overview
| 0.18 | |
| 0.192 | |
| - | |
| 0.195 | |
| 0.18 | |
| 0.063-0.3 | |
| 43 860 K | |
| 228 M | |
| 162 K | |
| 2.009 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
SKINBIO THERAP LS-01 Fundamental Data is available in our Financial Data APIs
- Net Revenue 162 K
- EBITDA -2 999 083
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get SKINBIO THERAP LS-01 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get SKINBIO THERAP LS-01 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
